![Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study]()
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled studyBavendiek, Udo; Berliner, Dominik; Dávila, Lukas Aguirre; Schwab, Johannes; Maier, Lars; Philipp, Sebastian A.; Rieth, Andreas; Westenfeld, Ralf; Piorkowski, Christopher; Weber, Kristina; Hänselmann, Anja; Oldhafer, Maximiliane; Schallhorn, Sven; von der Leyen, Heiko; Schröder, Christoph; Veltmann, Christian; Störk, Stefan; Böhm, Michael; Koch, Armin; Bauersachs, Johann; Bavendiek, Udo; Bauersachs, Johann; Koch, Armin; von der Leyen, Heiko; Veltmann, Christian; Böhm, Michael; Störk, Stefan; Tebbe, Ulrich; von Haehling, Stephan; Haass, Markus; Anker, Stefan; Mohacsi, Paul; Pölzl, Gerhard; Trampisch, Helmut; Dávila, Lukas Aguirre; Weber, Kristina; Zimmermann, Silke; Neuhaus, Barbara · European Journal of Heart Failure · 2019